Among these hepatokines are fetuin A, follistatin, HFREP1, LECT2, PEDF, and ectodysplasin, collectively exacerbating insulin resistance in skeletal muscle and adipose tissue through the activation of the c-Jun N-terminal kinase signaling pathway. The gene discussed is AHSG; the disease is Insulin resistance.